YANKCOM Partnership Invests $1.10 Million in UnitedHealth Group Incorporated (NYSE:UNH)

YANKCOM Partnership bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,165 shares of the healthcare conglomerate’s stock, valued at approximately $1,095,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Kathleen S. Wright Associates Inc. bought a new stake in shares of UnitedHealth Group during the third quarter worth $27,000. West Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $32,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $37,000. Finally, Friedenthal Financial bought a new stake in UnitedHealth Group in the third quarter valued at about $51,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $539.50 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a 50-day simple moving average of $533.81 and a two-hundred day simple moving average of $564.94. The stock has a market capitalization of $496.49 billion, a price-to-earnings ratio of 34.81, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the company posted $5.83 EPS. The company’s revenue was up 6.8% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

Wall Street Analyst Weigh In

UNH has been the topic of a number of analyst reports. Bank of America cut their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Oppenheimer boosted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. UBS Group lowered their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Finally, Piper Sandler lowered their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.